🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
1.240
-0.090 (-6.77%)
At close: Nov 20, 2026, 4:00 PM EST
1.249
+0.009 (0.71%)
After-hours: Nov 20, 2026, 7:34 PM EST

Seres Therapeutics Statistics

Total Valuation

MCRB has a market cap or net worth of $12.64 million. The enterprise value is $30.89 million.

Market Cap12.64M
Enterprise Value 30.89M

Important Dates

The last earnings date was Wednesday, November 4, 2026, before market open.

Earnings Date Nov 4, 2026
Ex-Dividend Date n/a

Share Statistics

MCRB has 10.20 million shares outstanding. The number of shares has increased by 10.70% in one year.

Current Share Class 10.20M
Shares Outstanding 10.20M
Shares Change (YoY) +10.70%
Shares Change (QoQ) +2.84%
Owned by Insiders (%) 0.51%
Owned by Institutions (%) 10.07%
Float 8.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 5.95
Forward PS 1.99
PB Ratio 0.58
P/TBV Ratio 0.59
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 14.53
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.65, with a Debt / Equity ratio of 1.67.

Current Ratio 1.65
Quick Ratio 1.56
Debt / Equity 1.67
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -144.35% and return on invested capital (ROIC) is -44.47%.

Return on Equity (ROE) -144.35%
Return on Assets (ROA) -44.85%
Return on Invested Capital (ROIC) -44.47%
Return on Capital Employed (ROCE) -147.12%
Weighted Average Cost of Capital (WACC) 1.92%
Revenue Per Employee $32,197
Profits Per Employee -$711,409
Employee Count66
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -95.67% in the last 52 weeks. The beta is 0.56, so MCRB's price volatility has been lower than the market average.

Beta (5Y) 0.56
52-Week Price Change -95.67%
50-Day Moving Average 2.56
200-Day Moving Average 6.10
Relative Strength Index (RSI) 21.40
Average Volume (20 Days) 93,425

Short Selling Information

The latest short interest is 342,237, so 3.36% of the outstanding shares have been sold short.

Short Interest 342,237
Short Previous Month 312,339
Short % of Shares Out 3.36%
Short % of Float 3.81%
Short Ratio (days to cover) 4.06

Income Statement

In the last 12 months, MCRB had revenue of $2.13 million and -$46.95 million in losses. Loss per share was -$4.88.

Revenue2.13M
Gross Profit -38.08M
Operating Income -66.20M
Pretax Income -46.95M
Net Income -46.95M
EBITDA -63.31M
EBIT -66.20M
Loss Per Share -$4.88
Full Income Statement

Balance Sheet

The company has $17.53 million in cash and $35.77 million in debt, with a net cash position of -$18.24 million or -$1.79 per share.

Cash & Cash Equivalents 17.53M
Total Debt 35.77M
Net Cash -18.24M
Net Cash Per Share -$1.79
Equity (Book Value) 21.36M
Book Value Per Share 2.13
Working Capital 13.53M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.94 million and capital expenditures -$29,000, giving a free cash flow of -$63.97 million.

Operating Cash Flow -63.94M
Capital Expenditures -29,000
Depreciation & Amortization 2.89M
Net Borrowing n/a
Free Cash Flow -63.97M
FCF Per Share -$6.27
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -3,115.15%
Pretax Margin -2,209.55%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MCRB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -10.70%
Shareholder Yield -10.70%
Earnings Yield -393.16%
FCF Yield -506.02%

Analyst Forecast

The average price target for MCRB is $17.00, which is 1,270.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target $17.00
Price Target Difference 1,270.97%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (3Y) -29.75%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on April 22, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date Apr 22, 2025
Split Type Reverse
Split Ratio 1:20

Scores

MCRB has an Altman Z-Score of -23.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -23.07
Piotroski F-Score 2